12.04.2015 - Generic drugmaker Mylan has made an offer of $ $28.86 billion in stock and cash to acquire rival Perrigo. A merger of the two major players would create a leader in specialty drugs...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)